A prospective, randomised comparison of Nd:YAG laser iridotomy.and operative peripheral iridectomy in the fellow eye of S2 patients presenting with acute angle closure glaucoma has been undertaken. Nd:YAG laser iridotomy resulted in a sig nificantly higher incidence of iris bleeding at the time of treatment (p<O.OS), higher intraocular pressure one hour (p<O.02) and three hours (p<O.02) following treat ment, and a higher incidence of focal corneal oedema 24 hours following treatment (p<O.OOl). One laser treated patient developed acute angle closure glaucoma two weeks following treatment despite the presence of a small patent iridotomy.
Argon l and Nd:YAG 2 laser iridotomy have already largely superseded operative periph eral iridectoml in the treatment of angle closure glaucoma. 4 Laser surgery is more con venient and less costly than conventional sur gery. 5 Rare but serious operative complications such as endophthalmitis, flat anterior chamber and malignant glaucoma, are completely eliminated. However laser surgery should not be regarded as non invasive. 6 Several studies have compared argon laser and Nd:YAG laser iridotomy. Nd:YAG laser iridotomy requires less laser energy, produces fewer short term complications, and has a much lower rate of delayed iridotomy closure than argon laser iridotomy. 7 -l2 Nd:YAG laser iridotomy hs not been compared with oper ative peripheral iridectomy in a prospective study. Peripheral iridectomy is a remarkably 'safe' operation, with few short or long term complications. 13 We are currently performing a long term prospective randomised compari son of these treatments in a variety of forms of angle closure glaucoma, and our initial results in the treatment of the fellow eye following acute angle closure glaucoma are presented in this paper.
Material and Method
Ethical approval of the study was obtained from the Regional Surgical Specialties Ethical Committee. Consecutive patients with acute angle closure glaucoma in one eye were accepted into the trial if the referring opthal mologist believed the patient to be suitable for either Nd:YAG laser iridotomy or oper ative peripheral iridectomy in the fellow eye. If the fellow eye had an intraocular pressure greater than 21 mmHg or a cup:disc ratio greater than 0.6 the patient was excluded from the study. Informed patient consent to inclusion in the trial was obtained before randomisation.
Initial examination included assessment of corrected visual acuity, intraocular pressure, Goldman gonioscopy, slit lamp examination of the lens, and fundal examination. Specular microscopy was performed using a Keeler Konan Pocklington specular microscope. Several central fields were photographed and stored for later analysis.
Forty-eight hours prior to surgical or laser treatment all systemic and topical introcular pressure lowering agents, other than G Pil ocarpine 2%, were discontinued. One drop of G Pilocarpine 2% was instilled one hour before treatment. 
Post treatment assessment
Goldman applanation tonometry was performed one, two, three, six and 24 hours following treat ment. A Perkins hand held applanation tonometer was used to measure the early post operative intra ocular pressure in some surgical patients who had had a general anaesthetic. Systemic and topical intraocular pressure lowering agents were withheld unless the pressure rose above 40 mm Hg.
Twenty four hours after treatment the cornea was examined and focal endothelial damage scored as 0 (no change present), + (focal granularity), or ++ (focal full thickness corneal oedema). Iritis was judged to be present if there were more than five white cells per field using a 3 mm long slit beam.
The presence of dispersed pigment particles in the aqueous was not judged to be indicative of iritis.
Intraocular pressure was measured, the iridotomy or iridectomy inspected for patency, and the lens examined. No topical treatment was given unless significant iritis was present, in which case G Beta methasone 0.1 % four times daily for one week was prescribed. Mydriatics were not used.
Follow up
Patients were assessed one week, one month, six months, and 12 months following treatment. The pupil was dilated using G. Phenylephrine 10% one month following treatment in order to detect pos terior synechiae, and to examine the lens and fun dus. Six months following treatment specular microscopy, gonioscopy and pilocarpine/phenyl ephrine provocation testing were performed.
Goldman gonioscopy was performed on all 
Specular microscopy analysis
Patients were coded by number, and endothelial cell counts were performed by an observer unaware of the coding system. Using standardised print magnification and a transparent grid, three repre' sentative fields of 0.05 mm2 were chosen for each patient, and the cells within these fields were counted. The mean value for the three areas was then calculated.
Statistical analysis
Where appropriate the unpaired Student t test or the chi squared test were used to test the signifi cance of differences between the two groups.
Results
Twenty six patients in each group have now completed at least six months of follow-up. Thirteen patients from the surgical group and sixteen patients from the laser treated group have completed one year of follow-up. The current mean follow-up time for the surgical group is 11.7 ± 8.7 months, and that of the laser treated group 16.1 ± 11.0 months (t test NS). Two patients in the laser treated group have died, in each case approximately nine Tables I and II. A patent laser iridotomy was obtained at the initial treatment session in 25 patients. Tr eatment sessions on three consecutive days were needed to obtain a patent iridotomy in one patient. A patent iridectomy was pro duced in all surgical patients. A mean of 3.1 ± 2.6 pulses (range 1-10) with a mean total energy of 25.8 ± 21.4 mJ (range 4.9-72.9) was used in laser treatment. One pulse was sufficient to create an adequate iridotomy in 11 patients, and less than 10 mJ total energy was used in 10 patients. Slight iris bleeding occurred at the time of treatment in 15 laser patients and seven surgical patients (X 2 test p<0.05). There were no other operative complications.
Immediate post treatment assessment
The mean intraocular pressure before treat ment and one, two, three and six hours fol lowing treatment are shown in Fig. 1 . Complete data was available in nine surgically treated patiens and 15 laser treated patients. The groups were significantly different at one hour and three hours using the unpaired stu dent t test, p<0.02. Two surgically treated Of the 15 laser treated patients with com plete intraocular pressure data, the peak pres sure occurred one hour following treatment in seven, at two hours in four, and at three hours in four. In all but two cases the intraocular pressure had returned to normal six hours fol lowing treatment.
The results of examination 24 hours fol lowing treatment are shown in Table III .
Focal corneal oedema was most marked 24 hours following laser treatment, and had fully resolved after one week in all cases. The total laser energy used to treat the 15 patients who subsequently developed focal corneal oedema was 30.95 ±21.6 mJ, compared to 18.2 ± 19.7 mJ for those who did not. This difference was not statistically significant. The total laser energy used to treat the six patients who subsequently developed mtls was 39.75 ± 16.2 mJ, compared to 20.7 ± 18.2 mJ for those who did not. Again this difference was not statistically significant.
Six surgical patients were found to have minimal focal lens opacities at the iridectomy site due to mild operative trauma to the anterior lens capsule. These opacities were not progressive and did not lead to visual loss during the follow-up period. Two laser treated patients developed focal lens opacities under lying the treatment site. In one case a faint haze was present deep to the anterior capsule, with no subsequent progression or loss of vision. The second case developed polychro matic crystals in the anterior lens cortex underlying the treatment site, with sub- 
One month follow-up
One laser treated patient developed acute angle closure glaucoma three weeks following treatment. The patient had been using cyclo pentolate 1 % drops to the other eye, and may have inadvertently contaminated the affected eye. Following treatment with pilocarpine 2% the intraocular pressure returned to normal.
The iridotomy was small (50 fA, x 50 fA,) but patent. Nd: YAG laser enlargement of the iri dotomy was performed, resulting in no further symptoms. A subsequent pilocarpine/ phenylephrine provocation test was negative. One patient was found to have developed iridotomy closure two weeks following treat ment and further laser treatment to re-open the iridotomy was performed.
Posterior synechiae developed in three sur gical patients, and three laser treated patients. Two of the surgical patients and one of the laser treated patients had had iritis at the 24 hours post treatment examination. The adhesions were of minimal extent in all cases, did not progress, and were not associated with subsequent cataract development or visual loss during the follow-up period of the study.
Six month follow-up
Table IV summarises the findings in the two groups of six months following treatment.
When compared with pre-treatment measurements visual acuity was unchanged, or changed by only one line in all surgical patients. However in the laser treated group visual acuity deteriorated by two or more lines in two patients. These patients had developed nuclear cataract--one in a previously clear lens, and one in a lens with pre-existing nuclear cataract.
The mean intraocular pressure was 14.5 ± 2.7 and 15.0 ± 3.2 mm Hg in the sur gical and laser groups respectively. One laser treated patient had an intraocular pressure of 25 mm Hg. All other patients had an intra ocular pressure of less than or equal to 21 mm Hg, and no patient required topical medication.
All iridotomies and iridectomies were patent. Gonioscopy revealed an open angle in all surgical patients, with focal goniosyne chiae adjacent to the iridectomy in two patients. Two laser treated patients had partly closed angles on Goldman gonioscopy, but the angles were open on indentation. One of these two patients had focal areas of goniosy nechiae adjacent to the iridotomy site.
No patient developed more than a 10% change in the cup:disc ratio, and no patient developed pathological optic disc cupping.
Pilocarpine/phenylephrine provocation tests were performed on 14 surgical patients and 23 laser patients. All tests were negative.
Satisfactory pre-treatment and six months post treatment specular micrographs were obtained in seven surgical patients and nine laser treated patients (see Table V ). The two groups did not significantly differ in mean endothelial cell count either before or six months following treatment. There was no significant percentage change in endothelial cell count following treatment in either group, and no difference between the two groups. Reduced endothelial cell density following argon laser iridotomy has been described by some workers, 7 but others have found no change. 29 We found no significant change in endothelial cell density following Nd:YAG laser iridotomy, confirming previous stud ies. 7 , 30 No significant change in endothelial cell density following operative peripheral iri dectomy was found in our study, again con firming the results of other workers. 30 , 31 The incidence of iritis and posterior syn echiae was similar following laser iridotomy and operative iridectomy. Focal lens opacities were found underlying the laser treatment site in two patients. Focal opacities induced by Nd: YAG laser photo disruption are rare, 21 , 24 , 32 in contrast to a much higher incidence fol lowing argon laser iridotomy. l , 7 , 10 , 11 , 12 We found six cases of small focal lens opacities at the site of operative peripheral iridectomy. Focal opacities, whether caused by argon laser iridotomy, Nd:YAG laser iridotomy or operative peripheral iridectomy have pre viously been found to be non-progressive and do not lead to visual loss. However one of our laser treated patients lost one line of visual acuity due to nuclear cataract following the development of a focal opacity at the time of treatment.
Long term glaucoma outcome
There was no significant difference in the mean intraocular pressure of the two groups six months following treatment, or at the time of most recent follow-up. Optic disc appear ance remained unchanged in all eyes, and gonioscopic appearances six months follow ing treatment were similar in the two groups. Two laser treated eyes had areas of angle closure which could be opened on indenta tion. Wishart has reported progressive angle narrowing in four eyes following Nd:YAG laser iridotomy, with widening of the angle on performing a further laser iridotomy. 21 It is possible that small iridotomies do not fully overcome iris bombe.
Long term visual outcome
While four laser treated patients lost two or more lines of visual acuity due to cataract development during the follow-up period, and no surgical patients lost vision, this differ ence was not statistically significant. Del Priore reported progression of cataract fol lowing Nd:YAG laser iridotomy in two of forty three patients. IO On long term follow-up approximately 10-15% of fellow eyes sub jected to peripheral iridectomy develop catar act sufficient to reduce visual acuity by two or more lines. 18 , 33 These figures compare with an incidence of 8% among fellow eyes treated conservatively. 34
Conclusion
While the follow-up period of our study was only 11.8 months, our findings suggest that the short term complications of Nd:YAG laser iridotomy do not adversely affect the long term outcome. Short term complications may be minimised by appropriate iridotomy technique. Oral acetazolamide or a topical beta-blocker given prior to treatment will reduce the incidence of post treatment intra ocular pressure elevation. 2s The use of low energy laser pulses in conjunction with a Wise 103 dioptre contact lens should minimise endothelial trauma. 9 The production of a large iridotomy will minimise the risk of sub sequent acute angle closure glaucoma. 16
Nd:YAG laser iridotomy and operative peripheral iridectomy appear to have a similar long term outcome. We are currently under taking a five year prospective comparison of Nd: YAG laser iridotomy and operative per ipheral iridectomy in 200 patients in order to test further this hypothesis. Bearing in mind the convenience of laser treatment, and the lack of possible anaesthetic complications, Nd: YAG laser iridotomy must remain the treatment of choice in angle closure glaucoma. 
